E-LIB Suche - Ergebnisse für: Favalli, Ennio G.

1

E069 Bimekizumab maintained efficacy responses through 52 w..:

Tillett, William R ; Merola, Joseph F ; Tanaka, Yoshiya...
Rheumatology. 63 (2024) Supplement_1 - p. , 2024

Link: https://doi.org/10.1093/..

2

E067 Bimekizumab maintained efficacy responses through 52 w..:

Tillett, William R ; Merola, Joseph F ; Tanaka, Yoshiya...
Rheumatology. 63 (2024) Supplement_1 - p. , 2024

Link: https://doi.org/10.1093/..

3

Real‐World Six‐ and Twelve‐Month Drug Retention, Remission,..:

Michelsen, Brigitte ; Georgiadis, Stylianos ; Di Giuseppe, Daniela...
Arthritis Care & Research. 74 (2022) 7 - p. 1205-1218 , 2022

Link: https://doi.org/10.1002/..

4

Certolizumab Pegol Treatment in Patients with Axial-Spondyl..:

van der Horst-Bruinsma, Irene E. ; Robinson, Philip C. ; Favalli, Ennio G....
Rheumatology and Therapy. 9 (2022) 6 - p. 1481-1497 , 2022

Link: https://doi.org/10.1007/..

5

Secukinumab inHLA‐B27associated uveitis:

Miserocchi, Elisabetta ; Giuffre, Chiara ; Caporali, Roberto.
Clinical & Experimental Ophthalmology. 49 (2021) 4 - p. 388-389 , 2021

Link: https://doi.org/10.1111/..

6

Golimumab effectiveness in biologic inadequate responding p..:

Iannone, Florenzo ; Favalli, Ennio G. ; Caporali, Roberto...
Joint Bone Spine. 88 (2021) 1 - p. 105062 , 2021

Link: https://doi.org/10.1016/..

7

Biologic therapy and spinal radiographic progression in pat..:

Baraliakos, Xenofon ; Gensler, Lianne S. ; D'Angelo, Salvatore...
Therapeutic Advances in Musculoskeletal Disease. 12 (2020) - p. 1759720X2090604 , 2020

Link: https://doi.org/10.1177/..

8

Understanding the Role of Interleukin-6 (IL-6) in the Joint..:

Favalli, Ennio G.
Rheumatology and Therapy. 7 (2020) 3 - p. 473-516 , 2020

Link: https://doi.org/10.1007/..

9

Efficacy and retention rate of adalimumab in rheumatoid art..:

Favalli, Ennio G. ; Becciolini, Andrea ; Carletto, Antonio...
Rheumatology International. 40 (2019) 2 - p. 263-272 , 2019

Link: https://doi.org/10.1007/..

10

Two‐year persistence of golimumab as second‐line biologic a..:

Favalli, Ennio G. ; Sinigaglia, Luigi ; Becciolini, Andrea...
International Journal of Rheumatic Diseases. 21 (2017) 2 - p. 422-430 , 2017

Link: https://doi.org/10.1111/..

11

Real-World Six- and Twelve-Month Drug Retention, Remission,..:

Michelsen, Brigitte ; Georgiadis, Stylianos ; Di Giuseppe, Daniela...
Arthritis Care and Research; 74(7). , 2022

Link: https://hdl.handle.net/2..

12

Real-world 6 and 12-month drug retention, remission and res..:

Michelsen, Brigitte ; Georgiadis, Stylianos ; Di Giuseppe, Daniela...
info:eu-repo/semantics/altIdentifier/pmid/33460531. , 2022

Link: http://hdl.handle.net/24..

13

Real-World Six- and Twelve-Month Drug Retention, Remission,..:

Michelsen, Brigitte ; Georgiadis, Stylianos ; Di Giuseppe, Daniela...
https://pure.au.dk/portal/en/publications/0c4dfa04-7747-44a0-96e8-1dea17fa2280. , 2022

Link: https://pure.au.dk/porta..

14

Real-World Six- and Twelve-Month Drug Retention, Remission,..:

Michelsen, Brigitte ; Georgiadis, Stylianos ; Di Giuseppe, Daniela...
10.1002/acr.24560. , 2022

Link: http://hdl.handle.net/10..

15

Real-world 6 and 12-month Drug Retention, Remission and Res..:

Michelsen, Brigitte ; Georgiadis, Stylianos ; Di Giuseppe, Daniela...
Arthritis Care & Research. , 2022

Link: https://hdl.handle.net/2..